BIOMAT Database Logo BIOMAT Database Logo

Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies. 1990

R Tan-Lim, and J C Bystryn
Department of Dermatology, New York University School of Medicine, NY 10016.

We determined the circulating levels of pemphigus antibodies in 11 patients with pemphigus treated with plasmapheresis, corticosteroids, and immunosuppressive drugs and in 11 patients treated with corticosteroids and immunosuppressive drugs alone. Three weeks after hospitalization, the average titer of pemphigus antibodies had decreased from admission levels by 83% in patients treated with plasmapheresis but by only 18% in the other group (p less than 0.05). These results suggest that plasmapheresis, in conjunction with high doses of corticosteroids and immunosuppressive drugs, reduces circulating levels of pemphigus antibodies more rapidly than conventional therapy.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010392 Pemphigus Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS. Pemphigus Vulgaris,Pemphigus Foliaceus,Foliaceus, Pemphigus
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000305 Adrenal Cortex Hormones HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE. Adrenal Cortex Hormone,Corticoid,Corticoids,Corticosteroid,Corticosteroids,Cortex Hormone, Adrenal,Hormone, Adrenal Cortex,Hormones, Adrenal Cortex

Related Publications

R Tan-Lim, and J C Bystryn
Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris.
June 1979, Archives of dermatology,
R Tan-Lim, and J C Bystryn
Plasmapheresis therapy of pemphigus.
November 1988, Archives of dermatology,
R Tan-Lim, and J C Bystryn
[Adjuvant therapy of pemphigus with plasmapheresis].
September 1981, Orvosi hetilap,
R Tan-Lim, and J C Bystryn
Plasmapheresis therapy of pemphigus and bullous pemphigoid.
September 1988, Seminars in dermatology,
R Tan-Lim, and J C Bystryn
Paraneoplastic pemphigus: potential therapeutic effect of plasmapheresis.
May 1996, The British journal of dermatology,
R Tan-Lim, and J C Bystryn
Bullous eruption with circulating pemphigus-like antibodies following interferon-alpha therapy.
January 1993, Dermatology (Basel, Switzerland),
R Tan-Lim, and J C Bystryn
[Circulating antibodies and the development of pemphigus].
January 1980, Annales de dermatologie et de venereologie,
R Tan-Lim, and J C Bystryn
Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid.
February 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
R Tan-Lim, and J C Bystryn
Human plasmapheresis and its effect on antibodies.
November 1957, Journal of immunology (Baltimore, Md. : 1950),
R Tan-Lim, and J C Bystryn
Pemphigus, pregnancy, and plasmapheresis.
May 2004, Cutis,
Copied contents to your clipboard!